Koga, T., Sumiyoshi, R., Furukawa, K., Sato, S., Migita, K., Shimizu, T., . . . Kawakami, A. (2020). Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still’s disease from sepsis. Arthritis Res Ther.
استشهاد بنمط شيكاغوKoga, Tomohiro, et al. "Interleukin-18 and Fibroblast Growth Factor 2 in Combination Is a Useful Diagnostic Biomarker to Distinguish Adult-onset Still’s Disease From Sepsis." Arthritis Res Ther 2020.
MLA استشهادKoga, Tomohiro, et al. "Interleukin-18 and Fibroblast Growth Factor 2 in Combination Is a Useful Diagnostic Biomarker to Distinguish Adult-onset Still’s Disease From Sepsis." Arthritis Res Ther 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.